Japanese Society of Nuclear Medicine (JSNM) was established in 1964. The main aim of JSNM is the appropriate development of applications for radioactive substances and stable nuclides in medicine. Towards this end, JSNM promotes the exchange of ideas information, and research in nuclear medicine. JSNM is interested in international collaboration for the development of nuclear medicine. Through its activities, JSNM contributes to the development of medicine and society, not only in Japan but also around the world. JSNM currently has over 3,500 members, comprising physicians, physicists, chemists, pharmacists, technologists, and others interested in the clinical and investigational use of radiopharmaceuticals and related fields. The JSNM membership provides exclusive professional, educational and personal benefits.
|The 7th CJK Conference on Nuclear Medicine||2016/04/18 - 17:04|
|2016 Asian Nuclear Medicine Board Examination||2016/02/26 - 14:19|
|JSNM’s Bid to Host the 2022 Congress of the WFNMB In Kyoto||2016/02/17 - 10:45|